Benjamin Hickey, EVP, Chief Commercial Officer at Mirati Therapeutics, Inc. (MRTX), sold 1,566 shares at $42.38 ($66K) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Seasonal sale ($66k) by EVP, Chief Commercial Officer — this insider has traded MRTX in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.38 | 619 | $26K | 39.5% |
| 2 | $42.38 | 947 | $40K | 60.5% |
| Total | $42.38 avg | 1,566 | $66K | 100% |
| Filing → |
| MRTX | SELL | 2024-01-09 | $246K | — | Filing → |
| MRTX | SELL | 2023-12-14 | $252K | — | Filing → |
| MRTX | SELL | 2023-01-10 | $189K | — | Filing → |